Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 30.23% is 11% below its 5-year average of 34.03%, near the low end of its 5-year range (20.17%–60.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 1.50% above its 12-month average of 29.78%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
30.23%
NET PROFIT MARGIN AVG TTM
29.78%
NET PROFIT MARGIN AVG 3Y
30.28%
NET PROFIT MARGIN AVG 5Y
32.71%
NET PROFIT MARGIN AVG 10Y
31.85%
NET PROFIT MARGIN AVG 15Y
28.32%
NET PROFIT MARGIN AVG 20Y
14.61%
CURRENT VS TTM AVG
+1.50%
CURRENT VS 3Y AVG
-0.16%
CURRENT VS 5Y AVG
-7.60%
CURRENT VS 10Y AVG
-5.11%
CURRENT VS 15Y AVG
+6.72%
CURRENT VS 20Y AVG
+106.94%
SECTOR MEDIAN · HEALTHCARE
9.05%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
+233.99%
vs the sector median at left
Regeneron Pharmaceuticals, Inc.
Market Cap
$78.57B
Net Profit Margin
30.23%
TTM Avg
29.78%
3Y Avg
30.28%
5Y Avg
32.71%
Market Cap
$81.51B
Net Profit Margin
2.47%
TTM Avg
3.11%
3Y Avg
3.37%
5Y Avg
3.60%
Market Cap
$87.16B
Net Profit Margin
8.77%
TTM Avg
8.57%
3Y Avg
8.64%
5Y Avg
8.95%
Market Cap
$69.46B
Net Profit Margin
17.48%
TTM Avg
12.73%
3Y Avg
10.54%
5Y Avg
8.34%
Market Cap
$60.00B
Net Profit Margin
5.33%
TTM Avg
8.06%
3Y Avg
8.30%
5Y Avg
8.27%
Market Cap
$100.24B
Net Profit Margin
1.18%
TTM Avg
1.05%
3Y Avg
1.09%
5Y Avg
0.48%
Market Cap
$53.87B
Net Profit Margin
0.62%
TTM Avg
0.54%
3Y Avg
0.18%
5Y Avg
-0.22%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. (REGN) | $78.57B | 30.23% | 29.78% | 30.28% | 32.71% |
| Elevance Health Inc. (ELV)vs › | $81.51B | 2.47% | 3.11% | 3.37% | 3.60% |
| Cigna Corporation (CI)vs › | $73.82B | 2.27% | 1.78% | 2.48% | 3.04% |
| HCA Healthcare, Inc. (HCA)vs › | $87.16B | 8.77% | 8.57% | 8.64% | 8.95% |
| Boston Scientific Corporation (BSX)vs › | $69.46B | 17.48% | 12.73% | 10.54% | 8.34% |
| Cencora, Inc. (COR)vs › | $60.57B | 0.78% | 0.49% | 0.59% | 0.22% |
| Becton, Dickinson and Company (BDX)vs › | $60.00B | 5.33% | 8.06% | 8.30% | 8.27% |
| McKesson Corporation (MCK)vs › | $100.24B | 1.18% | 1.05% | 1.09% | 0.48% |
| Cardinal Health, Inc. (CAH)vs › | $53.87B | 0.62% | 0.54% | 0.18% | -0.22% |
| GSK plc (GSK)vs › | $103.56B | 17.76% | 12.86% | 23.24% | 22.39% |
Operating Margin
24.7%
Net Profit Margin
30.2%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 30.23% |
| 2026-03-31 | 20.17% |
| 2025-12-31 | 21.74% |
| 2025-09-30 | 38.89% |
| 2025-06-30 | 37.86% |
| 2025-03-31 | 26.70% |
| 2024-12-31 | 24.22% |
| 2024-09-30 | 36.03% |
| 2024-06-30 | 40.38% |
| 2024-03-31 | 22.96% |
| 2023-12-31 | 33.77% |
| 2023-09-30 | 29.97% |
| 2023-06-30 | 30.66% |
| 2023-03-31 | 25.86% |
| 2022-12-31 | 35.06% |
| 2022-09-30 | 44.81% |
| 2022-06-30 | 29.82% |
| 2022-03-31 | 32.83% |
| 2021-12-31 | 45.01% |
| 2021-09-30 | 47.27% |
| 2021-06-30 | 60.31% |
| 2021-03-31 | 44.10% |
| 2020-12-31 | 47.43% |
| 2020-09-30 | 36.71% |
| 2020-06-30 | 45.97% |
| 2020-03-31 | 34.16% |
| 2019-12-31 | 42.50% |
| 2019-09-30 | 38.40% |
| 2019-06-30 | 12.24% |
| 2019-03-31 | 33.59% |
| 2018-12-31 | 42.56% |
| 2018-09-30 | 35.75% |
| 2018-06-30 | 34.29% |
| 2018-03-31 | 31.62% |
| 2017-12-31 | 10.97% |
| 2017-09-30 | 25.88% |
| 2017-06-30 | 26.38% |
| 2017-03-31 | 18.87% |
| 2016-12-31 | 20.63% |
| 2016-09-30 | 21.70% |
| 2016-06-30 | 16.18% |
| 2016-03-31 | 13.80% |
| 2015-12-31 | 14.12% |
| 2015-09-30 | 18.50% |
| 2015-06-30 | 19.49% |
| 2015-03-31 | 8.74% |
| 2014-12-31 | 13.73% |
| 2014-09-30 | 10.98% |
| 2014-06-30 | 13.93% |
| 2014-03-31 | 10.46% |
| 2013-12-31 | 15.86% |
| 2013-09-30 | 23.67% |
| 2013-06-30 | 19.09% |
| 2013-03-31 | 22.49% |
| 2012-12-31 | 113.46% |
| 2012-09-30 | 44.77% |
| 2012-06-30 | 25.21% |
| 2012-03-31 | 5.03% |
| 2011-12-31 | -43.46% |
| 2011-09-30 | -60.65% |
| 2011-06-30 | -57.98% |
| 2011-03-31 | -38.72% |
| 2010-12-31 | -10.92% |
| 2010-09-30 | -31.96% |
| 2010-06-30 | -21.98% |
| 2010-03-31 | -29.48% |
| 2009-12-31 | -37.70% |
| 2009-09-30 | -0.86% |
| 2009-06-30 | -16.59% |
| 2009-03-31 | -23.31% |
| 2008-12-31 | -56.45% |
| 2008-09-30 | -32.20% |
| 2008-06-30 | -30.43% |
| 2008-03-31 | -20.61% |
| 2007-12-31 | -20.19% |
| 2007-09-30 | -160.63% |
| 2007-06-30 | -120.63% |
| 2007-03-31 | -189.49% |
| 2006-12-31 | -299.35% |
| 2006-09-30 | -175.44% |
| 2006-06-30 | -122.42% |
| 2006-03-31 | -111.86% |
| 2005-12-31 | -170.29% |
| 2005-09-30 | -213.98% |
| 2005-06-30 | -164.97% |
| 2005-03-31 | -25.44% |
| 2004-12-31 | 5.93% |
| 2004-09-30 | -30.33% |
| 2004-06-30 | -51.20% |
| 2004-03-31 | 104.10% |
| 2003-12-31 | -91.09% |
| 2003-09-30 | -157.54% |
| 2003-06-30 | -272.84% |
| 2003-03-31 | -297.06% |
| 2002-12-31 | -726.65% |
| 2002-09-30 | -499.79% |
